References
- Bencardino K, Mauri G, Amatu A, et al. Oxaliplatin immune-induced syndrome occurs with cumulative administration and rechallenge: single institution series and systematic review study. Clin Colorectal Cancer. 2016 Feb.
- Ito I, Ito Y, Mizuno M, et al. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. Clin Exp Nephrol. 2012 Jun;16(3):490–494. doi: 10.1007/s10157-012-0620-8
- Ulusakarya A, Misra S, Haydar M, et al. Acute renal failure related to oxaliplatin-induced intravascular hemolysis. Med Oncol. 2010 Dec;27(4):1425–1426. doi: 10.1007/s12032-009-9263-3
- Arnold DM, Nazi I, Warkentin TE, et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013 Jul;27(3):137–145. doi: 10.1016/j.tmrv.2013.05.005
- Curtis BR, Kaliszewski J, Marques MB, et al. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol. 2006 Mar;81(3):193–198. doi: 10.1002/ajh.20516
- Kurian S, Macintyre J, Mushtaq M, et al. Oxaliplatin induced disseminated intravascular coagulation: a case report and review of literature. World J Gastrointest Oncol. 2012 Jul;4(7):181–183. doi: 10.4251/wjgo.v4.i7.181
- Arnold DM, Curtis BR, Bakchoul T. Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH. J Thromb Haemost. 2015 Apr;13(4):676–678. doi: 10.1111/jth.12852
- James E, Podoltsev N, Salehi E, et al. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect? Clin Colorectal Cancer. 2009 Oct;8(4):220–224. doi: 10.3816/CCC.2009.n.037
- Curtis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology. 2014;30(2):55–65.
- Anand A, Chauhan HK. Piperacillin and vancomycin induced severe thrombocytopenia in a hospitalized patient. Platelets. 2011;22(4):294–301. doi: 10.3109/09537104.2010.549973
- André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004 Jun;350(23):2343–2351. doi: 10.1056/NEJMoa032709
- Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol. 2003 Oct;14(10):1570–1577. doi: 10.1093/annonc/mdg417